Crescent Biopharma (CBIO) Prepaid Assets (2013 - 2026)

Crescent Biopharma (CBIO) has reported Prepaid Assets for 14 consecutive years, with $7.4 million the latest figure, recorded in Q2 2026.

• In Q2 2026, Prepaid Assets rose 368.58% year-over-year to $7.4 million; the TTM figure through Jun 2026 stood at $7.4 million (up 368.58% YoY), while the FY2025 annual figure was $5.5 million, up 14276.32% from the prior year.
• Prepaid Assets climbed to $7.4 million in Q2 2026 per CBIO's latest filing, from $6.4 million in the prior quarter.
• Across five years, Prepaid Assets topped out at $7.4 million in Q2 2026 and bottomed at $38000.0 in Q4 2024.
• Historically, Prepaid Assets has averaged $2.5 million across 5 years, with a median of $2.0 million in 2023.
• Annual changes were most pronounced in 2024 — Prepaid Assets slumped 98.1% — and 2025, when it jumped 14276.32%.
• Crescent Biopharma's Prepaid Assets stood at $2.8 million in 2022, then declined by 29.75% to $2.0 million in 2023, then plunged by 98.1% to $38000.0 in 2024, then surged by 14276.32% to $5.5 million in 2025, then soared by 35.69% to $7.4 million in 2026.
• Business Quant data shows CBIO's Prepaid Assets at $7.4 million in Q2 2026, $6.4 million in Q1 2026, and $5.5 million in Q4 2025.